- Using Lymphocyte Count To Predictor Survival Of Young Leukemia Patients
One simple blood test could predict relapse or survival for children and young adults with acute leukemias, researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center reported at the American Society of Ped ...
Article - News Staff - May 7 2007 - 2:14pm
- The Cost Of Gene Patents- An Expensive Example
The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25% of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has ...
Article - News Staff - May 7 2007 - 9:38pm
- Genetic Roots Of Bipolar Disorder Revealed
The likelihood of developing bipolar disorder depends in part on the combined, small effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself, a new study shows. However, targeting the enzy ...
Article - News Staff - May 8 2007 - 1:32am
- How To Steer A Moving Cell
Researchers at the University of California, San Diego (UCSD) School of Medicine have developed new technology which, combined with proteomics – the large-scale study of the structure and function of proteins and their functions – has allowed them to map a ...
Article - News Staff - May 8 2007 - 11:56am
- Biosensor Sniffs Out Explosives
Temple University School of Medicine researchers have developed a new biosensor that sniffs out explosives and could one day be used to detect landmines and deadly agents, such as sarin gas. To create the biosensor, Danny Dhanasekaran and colleagues geneti ...
Article - News Staff - May 8 2007 - 4:08pm
- Researches Discover Genetic 'shut Down' Trigger In Healthy Immune Cells
A fundamental genetic mechanism that shuts down an important gene in healthy immune system cells has been discovered that could one day lead to new therapies against infections, leukemia and other cancers. Results of a University of Pittsburgh School of M ...
Article - News Staff - May 9 2007 - 10:18am
- HPV Vaccine Against Virus Responsible For Cervical Cancer
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer. Results of a nationwide study of the vaccine will be published in the M ...
Article - News Staff - Feb 12 2011 - 7:19pm
- HPV Infection Linked To Throat Cancers
Researchers at the Johns Hopkins Kimmel Cancer Center have conclusive evidence that human papillomavirus (HPV) causes some throat cancers in both men and women. Reporting in the May 10 issue of the New England Journal of Medicine, the researchers found tha ...
Article - News Staff - May 9 2007 - 5:58pm
- Researchers Publish First Marsupial Genome Sequence
An international team, led by researchers at the Broad Institute of MIT and Harvard, and supported by the National Institutes of Health (NIH), today announced the publication of the first genome of a marsupial, belonging to a South American species of opos ...
Article - News Staff - May 10 2007 - 11:40am
- Oncolytic Viruses Plus Anti-cancer Drugs Work Better Than Either Alone
New scientific evidence is helping to build a compelling case for oncolytic viruses as a first-line and adjunctive treatment for many cancers. Reovirus, a non-pathogenic virus under development at Calgary, Alberta-based Oncolytics Biotech, has shown powerf ...
Article - News Staff - Aug 11 2007 - 11:14pm